Wild-Type Transthyretin Cardiac Amyloidosis Presenting As Progressive Heart Failure and Conduction Disease Despite Guideline-Directed Medical Therapy
Cureus · 26.05.2026
DOI: 10.7759/cureus.109667 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 26.05.2026. Verfasst von Srivane Richard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.
- Department of Cardiology, State University of New York Downstate Health Sciences University, Brooklyn, USA.
Zitieren
APA
Richard, S., Thomas, D., Gorantla, A., Devkota, S., & Graham-Hill, S. (2026). Wild-Type Transthyretin Cardiac Amyloidosis Presenting As Progressive Heart Failure and Conduction Disease Despite Guideline-Directed Medical Therapy. Cureus. https://doi.org/10.7759/cureus.109667
Vancouver
Richard S, Thomas D, Gorantla A, Devkota S, Graham-Hill S. Wild-Type Transthyretin Cardiac Amyloidosis Presenting As Progressive Heart Failure and Conduction Disease Despite Guideline-Directed Medical Therapy. Cureus. 2026. doi:10.7759/cureus.109667
BibTeX
@article{Richard2026,
author = {Richard, Srivane and Thomas, Dea and Gorantla, Asher and Devkota, Sameeksha and Graham-Hill, Suzette},
title = {Wild-Type Transthyretin Cardiac Amyloidosis Presenting As Progressive Heart Failure and Conduction Disease Despite Guideline-Directed Medical Therapy},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.109667}
}
EUVIMED